Results
1 -
7 of
7
(Click
here to explore results)
- Pain Therapeutics: Current and Future Treatment Paradigms, CHAPTER 5 Neurotransmitters and Other Non-Opiate Central Mechanisms. Simon E. Ward
, 2014
, Pages 171-196
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders. Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley
, 2012
, Pages 258-275
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 10 Glutamate Receptor Modulators as Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease. Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli, Ian J. Reynolds
, 2013
, Pages 237-265
- Allosterism in Drug Discovery, CHAPTER 13 Mechanism of Action of a GluN2C- and GluN2D-Selective NMDA Receptor Positive Allosteric Modulator. Katie L. Strong, Matthew P. Epplin, Yao Jing, Stephen F. Traynelis, Dennis C. Liotta
, 2017
, Pages 281-309
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 10 Alcohols and Phenols: Absorption, Distribution, Metabolism and Excretion. Zhuang Miao, R. Scott Obach
, 2010
, Pages 460-485
- Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
- Pain Therapeutics: Current and Future Treatment Paradigms, Subject Index
, 2014
, Pages 386-411